The Library
Supplementation of Vitamin D deficiency in patients with neuroendocrine tumors using over-the-counter Vitamin D3 preparations
Tools
Tools
Tools
Robbins, Helen L., Symington, Megan, Mosterman, Barbara, Goodby, Josie, Davies, Louise, Dimitriadis, Georgios K., Kaltsas, Gregory, Randeva, Harpal S. and Weickert, Martin O. (2018) Supplementation of Vitamin D deficiency in patients with neuroendocrine tumors using over-the-counter Vitamin D3 preparations. Nutrition and Cancer, 70 (5). pp. 748-754. doi:10.1080/01635581.2018.1470650
Research output not available from this repository, contact author.
Official URL: https://doi.org/10.1080/01635581.2018.1470650
Abstract
Vitamin D (vit-D) deficiency is highly prevalent in patients with gastro-entero-pancreatic neuroendocrine tumors (GEP-NET) and has been linked to reduced overall survival. We here assessed the vit-D status in 183 patients with GEP-NET at the time of their first presentation in the ARDEN NET Centre. We further examined the effect of simple advice to increase vit-D intake using over-the-counter vit-D preparations [colecalciferol (Vit-D3), 1,000-2,000 units/day], over a prospective observation period of 24 mo. At baseline, only 33.3% of patients showed vit-D sufficiency (25-OH-vit-D; >50 nmol/L), the remainder was insufficient (31.3%; 25-OH-vit-D; 25-50 nmol/L) or deficient (35.5%; 25-OH-vit-D; <25 nmol/L). Repeated advice to increase vit-D intake at routine 6-monthly follow-up appointments was associated with increased 25-OH-vit-D from 37.8 ± 3.5 nmol/L at baseline to 60.4 ± 5.6 nmol/L (P < 0.0001) and 56.8 ± 7.0 nmol/L (P = 0.039) after 12 and 24 mo. Percentage of vit-D insufficiency decreased from 66.6% at baseline to 44.9% and 46.2% after 12 and 24 months, respectively. Previous abdominal surgery, but not treatment with somatostatin analogues predicted 25-OH-vit-D levels in bootstrapped linear regression analyses (P = 0.037). In summary, simple advice to increase vit-D intake using over-the-counter preparations was associated with significant improvement of vit-D deficiency/insufficiency, although, 15% of GEP-NET patients remained deficient and may benefit from additional measures of vit-D replacement.
| Item Type: | Journal Article | ||||||
|---|---|---|---|---|---|---|---|
| Subjects: | R Medicine > R Medicine (General) R Medicine > RC Internal medicine R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) |
||||||
| Divisions: | Faculty of Medicine > Warwick Medical School > Biomedical Sciences Faculty of Medicine > Warwick Medical School > Biomedical Sciences > Translational & Experimental Medicine > Metabolic and Vascular Health (- until July 2016) Faculty of Medicine > Warwick Medical School > Biomedical Sciences > Translational & Experimental Medicine Faculty of Medicine > Warwick Medical School |
||||||
| Journal or Publication Title: | Nutrition and Cancer | ||||||
| Publisher: | Routledge | ||||||
| ISSN: | 0163-5581 | ||||||
| Official Date: | 21 May 2018 | ||||||
| Dates: |
|
||||||
| Volume: | 70 | ||||||
| Number: | 5 | ||||||
| Page Range: | pp. 748-754 | ||||||
| DOI: | 10.1080/01635581.2018.1470650 | ||||||
| Status: | Peer Reviewed | ||||||
| Publication Status: | Published | ||||||
| Access rights to Published version: | Restricted or Subscription Access |
Request changes or add full text files to a record
Repository staff actions (login required)
 |
View Item |
